2m 2m 2m 2m 2m 2m 2m
AURA BIOSCIS (AURA)
NASDAQ
$7.81+$0.005 (+0.06%)
Price as of Aug 21, 2026 7:30 PM EDT- $808.9MMarket Cap
- 19.08%1-Year Change
- BiotechnologyIndustry
AURA BIOSCIS (AURA)
$7.81+$0.005 (+0.06%)
AURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.80 | ||
Change | +$0.03 (+0.39%) | ||
Open | $7.77 | ||
High | $8.09 | ||
Low | $7.65 | ||
Previous Close | $7.77 | ||
Volume | 500,883 | ||
30-Day Average Volume | 686,777 | ||
1-Week Change | 1.43% | ||
1-Month Change | 10.95% | ||
1-Year Change | 19.08% | ||
3-Year Change | -23.53% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 103.7M | ||
Total Assets | $348.1M | ||
Market Cap | $808.9M | ||
Enterprise Value | $741.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$45.6M | ||
Free Cash Flow | -$32.5M | ||
EBIT | -$45.6M | ||
EBITDA | -$45.3M | ||
Net Working Capital | $309.5M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -16 | ||
PEG | -4 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue